Why it’s interesting
Aletta is a working medical device with a public, close-up demonstration, not a concept render. After a patient places an arm inside, the system combines near-infrared imaging, ultrasound and Doppler ultrasound to locate a suitable vein and distinguish it from arteries. Its mechanisms then handle the tourniquet, disinfection, needle insertion, tube changes, needle removal and bandage. The AI contribution is tied to imaging and vein selection, while the visual hook is seeing many small clinical actions become one continuous robotic sequence.
How to try it
Treat this as something to watch, not a home gadget or a do-it-yourself procedure. Open Vitestro's Aletta page for the official photos, workflow explanation and patient-facing material. For regulatory context, compare Vitestro's August 2026 announcement with the FDA press release and De Novo database entry. Real use is limited to facilities that provide the device: a trained phlebotomist starts the session, supervises it and remains available if the system pauses or cannot find a suitable vein.
Requirements and sources
Aletta is a paid clinical device rather than a consumer product. The FDA authorization covers adults in outpatient settings and requires oversight by a trained phlebotomist. Vitestro says the device carries a CE mark and is being deployed in European clinical and commercial settings; U.S. authorization does not mean it is available everywhere. This entry recommends only the official demonstration and makes no judgment about medical suitability, treatment, safety for an individual, hospital choice or purchasing. The cover is an official Vitestro product photograph referenced remotely with attribution.